» Articles » PMID: 12975033

Nutrition Therapy for Diabetic Gastroparesis

Overview
Journal Curr Diab Rep
Publisher Current Science
Specialty Endocrinology
Date 2003 Sep 17
PMID 12975033
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The management of diabetic gastroparesis often represents a significant clinical challenge in which the maintenance of nutrition is pivotal. Gastric emptying is delayed in 30% to 50% of patients with longstanding type 1 or type 2 diabetes and upper gastrointestinal symptoms also occur frequently. However, there is only a weak association between the presence of symptoms and delayed gastric emptying. Acute changes in blood glucose concentrations affect gastric motility in diabetes; hyperglycemia slows gastric emptying whereas hypoglycemia may accelerate it; blood glucose concentrations may also influence symptoms. It is now recognized that gastric emptying is a major determinant of postprandial glycemia and, therefore, there is considerable interest in the concept of modulating gastric emptying, by dietary or pharmacologic means, to optimize glycemic control in diabetes.

Citing Articles

Case report: rare case of mechanical bowel obstruction due to strangulation by gastric stimulator electrodes.

Lederhuber H, Axer S, Ihle C BMC Surg. 2015; 15:35.

PMID: 25881095 PMC: 4381395. DOI: 10.1186/s12893-015-0022-4.


Treatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapies.

Pang B, Zhou Q, Li J, Zhao L, Tong X World J Gastroenterol. 2014; 20(21):6504-14.

PMID: 24914371 PMC: 4047335. DOI: 10.3748/wjg.v20.i21.6504.


Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Parkman H, Camilleri M, Farrugia G, McCallum R, Bharucha A, Mayer E Neurogastroenterol Motil. 2009; 22(2):113-33.

PMID: 20003077 PMC: 2892213. DOI: 10.1111/j.1365-2982.2009.01434.x.


Diabetic gastroparesis: diagnosis and management.

Ma J, Rayner C, Jones K, Horowitz M Drugs. 2009; 69(8):971-86.

PMID: 19496627 DOI: 10.2165/00003495-200969080-00003.


Gastroparesis: current diagnostic challenges and management considerations.

Waseem S, Moshiree B, Draganov P World J Gastroenterol. 2008; 15(1):25-37.

PMID: 19115465 PMC: 2653292. DOI: 10.3748/wjg.15.25.


References
1.
Nauck M, Holst J, Willms B, Schmiegel W . Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes. Exp Clin Endocrinol Diabetes. 1997; 105(4):187-95. DOI: 10.1055/s-0029-1211750. View

2.
Zander M, Madsbad S, Madsen J, Holst J . Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet. 2002; 359(9309):824-30. DOI: 10.1016/S0140-6736(02)07952-7. View

3.
Jones K, Berry M, Kong M, Kwiatek M, Samsom M, Horowitz M . Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care. 1999; 22(2):339-44. DOI: 10.2337/diacare.22.2.339. View

4.
Jones K, Wishart J, Berry M, Abitbol J, Horowitz M . Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis. Aliment Pharmacol Ther. 2000; 14(7):937-43. DOI: 10.1046/j.1365-2036.2000.00790.x. View

5.
Jones K, Russo A, Stevens J, Wishart J, Berry M, Horowitz M . Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001; 24(7):1264-9. DOI: 10.2337/diacare.24.7.1264. View